Six months after Eli Lilly began selling discounted vials of its blockbuster weight loss drug Zepbound, the company expanded the offering Feb. 25 to include cheaper, high-dose Zepbound vials.

The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi ... priced at a similar level to the glucagon injection kits available on the market, with a ...

Several individuals enrolled in a phase 3 trial for Eli ... acting GIP/GLP-1/glucagon receptor agonist that is taken as a pill. A Seeking Alpha request for comment from Lilly has not yet been ...